SEARCH

SEARCH BY CITATION

References

  • Canger R, Battino D, Canevini MP, Fumarola C, Guidolin L, Vignoli A, Mamoli D, Palmieri C, Molteni F, Granata T, Hassibi P, Zamperini P, Pardi G, Avanzini G. (1999) Malformations in offspring of women with epilepsy: a prospective study. Epilepsia40:12311236.
  • Dravet C, Julian C, Legras C, Magaudda A, Guerrini R, Genton P, Soulayrol S, Giraud N, Mesdjian E, Trentin G, Roger J, Ayme S. (1992) Epilepsy, antiepileptic drugs, and malfoprmations in children of women with epilepsy: a French prospective cohort study. Neurology42(Suppl. 5):7582.
  • Duncan S, Mercho S, Lopes-Cendes I, Seni MH, Benjamin A, Dubeau F, Andermann F, Andermann E. (2001) Repeated neural tube defects and valproate monotherapy suggest a pharmacogenetic abnormality. Epilepsia42:750753.
  • Eadie MJ, Vajda FJ. (2005) Should valproate be taken during pregnancy – a reappraisal?Ther Clin Risk Manag1:2126.
  • Editorial. (1982) Valproate and malformations. Lancetii:13131314.
  • Janz D. (1975) The teratogenic risk of antiepileptic drugs. Epilepsia16:159169.
  • Kaaja E, Kaaja R, Hiilesmaa V. (2003) Major malformations in offspring of women with epilepsy. Neurology60:575579.
  • Kaneko S, Battino D, Andermann E, Wada K, Kan R, Takeda A, Nakane Y, Ogawa Y, Avanzini G, Fumarola C, Granata T, Molteni F, Pardi G, Minotti L, Canger R, Dansky L, Oguni M, Lopes-Cendas I, Sherwin A, Andermann F, Seni MH, Okada M, Teranishi T. (1999) Congenital malformations due to antiepileptic drugs. Epilepsy Res33:145158.
  • Meador KJ, Baker GA, Browning N, Clayton-Smith J, Combs-Cantrell DT, Cohen M, Kalayjian LA, Kanner A, Liporace JD, Pennell PB, Privitera M, Loring DW. (2009) Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med360:15971605.
  • Meadow SR. (1970) Congenital abnormalities and anticonvulsant drugs. Proc R Soc Med63:4849.
  • Morrow J, Russell A, Guthrie E, Parsons L, Robertson I, Waddell R, Irwin B, McGivern RC, Morrison PJ, Craig J. (2006) Malformation risk of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry77:193198.
  • Olafsson E, Hallgrimsson JT, Hauser WA, Ludvigsson P, Gudnundsson G. (1998) Pregnancies of women with epilepsy: a population-based study in Iceland. Epilepsia39:887892.
  • Omtzigt JGC, Los FJ, Grobbee DE, Pijpers L, Jahoda MG, Brandenburg H, Stewart PA, Gaillard HL, Sachs ES, Wladimiroff JW. (1992) The risk of spina bifida aperta after first-trimester exposure to valproate in a prenatal cohort. Neurology42(Suppl. 5):119125.
  • Riley M, Halliday J. (2000) Birth defects in Victoria 1983–1998. Perinatal Data Collection Unit, Victorian Government of Human Services, Melbourne, Vic.
  • Samren EB, van Duijn CM, Koch S, Hiilesmaa VK, Klepel H, Bardy AH, Mannagetta GB, Deichl AW, Gaily E, Granstrom ML, Meinardi H, Grobbee DE, Hofman A, Janz D, Lindhout D. (1997) Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy. Epilepsia38:981990.
  • Tomson T, Battino D. (2009) Teratogenic effects of antiepileptic medications. Neurol Clin27:9931002.
  • Tomson T, Battino D, Bonizzoni E, Craig J, Lindhout D, Sabers A, Perucca E, Vajda F; EURAP Study Group. (2011) Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol10:609617.
  • Vajda FJE, Eadie MJ. (2005) Maternal valproate dosage and foetal malformations. Acta Neurol Scand112:137143.
  • Vajda FJ, O’Brien TJ, Hitchcock A, Graham J, Cook M, Lander C, Eadie MJ. (2004) Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian Registry of anti-epileptic drugs in pregnancy. J Clin Neurosci1:854858.
  • Vajda F, Hitchcock A, Graham J, Solinas C, O’Brien T, Lander C, Eadie M. (2006a) Foetal malformations and seizure control: 52 months data of the Australian Pregnancy Registry. Eur J Neurol13:645654.
  • Vajda F, O’Brien T, Hitchcock A, Graham J, Lander C, Eadie M. (2006b) Pregnancies in women with epilepsy. J R Coll Physicians Edinb36:201207.
  • Vajda FJ, Hitchcock A, Graham J, O’Brien T, Lander C, Eadie M. (2007a) The Australian register of antiepileptic drugs in pregnancy. The first 1002 pregnancies. Aust N Z J Obstet Gynaecol47:468474.
  • Vajda FJE, Lander CM, Hitchcock A, Graham J, Solinas C, O’Brien T, Eadie MJ. (2007b) Changing patterns of Australian prescribing of antiepileptic drugs in pregnancy and their possible consequences. J Clin Neurosci14:611617.
  • Vajda F, O’Brien T, Hitchcock A, Graham J, Lander C, Eadie M. (2007c) The Australian pregnancy register of antiepileptic drugs – aspects of data collection and analysis. J Clin Neurosci14:936942.
  • Vajda F, O’Brien T, Hitchcock A, Graham J, Lander C, Eadie M. (2008) Seizure control in antiepileptic drug–treated pregnancy. Epilepsia49:172175.
  • Vajda F, Hitchcock A, Graham J, O’Brien T, Lander C, Eadie M. (2010) The teratogenic risk of antiepileptic drug polytherapy. Epilepsia51:805810.
  • Vajda FJE, Graham J, Hitchcock AA, O’Brien TJ, Lander CM, Eadie MJ. (2011) Foetal malformations after exposure to antiepileptic drugs in utero assessed at birth and 12 months later. Observations from The Australian Pregnancy Register. Acta Neurol Scand124:912.